badguy3101
5 meses hace
LOL! Yup, still here WC! However, unlike a lost soul who is probably on disability or social security for the rest of their miserable life, I'm enjoying the breathtaking beauty of God's creation on Northern Michigan's Torch Lake with family and friends. Made a lot of $$ with God's blessing and SLEEK'S picks.
See WC, I realize the entire Hemp/MJ sector is currently dead so why would I waste my time arguing with a lost soul who is stuck on government peanut payouts and has alllllllll the time in their miserable life to post nonstop on IHUB??? LMAO!!!! No thanks! Oh, and thank you for wondering how I am doing!
SIPC
The Badguy
molee
5 meses hace
SIPP Industries Announces Milestone Achievements in Partnership with Calypso Pharmaceuticals
COSTA MESA, CA / ACCESSWIRE / August 1, 2024 / SIPP Industries, Inc. (OTC PINK:SIPC), a multifaceted corporation specializing in the manufacturing and distribution of commercial and consumer products within the cannabis industry, proudly announces successful distribution and production milestones in collaboration with its partner, Calypso Pharmaceuticals.
SIPP Industries and Calypso Pharmaceuticals have gained significant momentum within the Texas Hemp Industry by securing multiple key distributors and high-volume, multi-location retail storefronts in Dallas and Fort Worth. These outlets will carry an extensive range of products, including the entire lineup of Calypso Farms THCa Flower/Pre-Rolls, Calypso Pharmaceuticals 100mg hemp-derived Delta-9 White Lightning Syringes, and AVEINA 1000mg CBD Infused Body Lotion.
Additionally, SIPP Industries and Calypso Pharmaceuticals is set to launch a new production partnership with CHLL Brand, offering innovative products like a 100mg Delta-9 Hemp Derived Water Soluble Flavor Enhancer and a 12oz 25mg CBD Infused Flavorless Bottle of Water.
The Water Soluble Flavor Enhancer, utilizing a 1:1 ratio of CBD to hemp derived Delta-9, is designed to assist with anxiety and depression. The CBD's anxiolytic effects may help alleviate anxiety symptoms, while Delta-9 could contribute to mood regulation, offering a balanced approach to mental well-being.
The Flavorless Bottle of Water, containing 25mg of CBD per bottle, provides a convenient way to incorporate CBD into daily routines, potentially offering general wellness benefits, including stress relief and relaxation without the psychoactive effects of THC, catering to those seeking a mild, non-intoxicating option.
With the rapid increase in volume and growth, SIPP Industries anticipates booking revenues during this quarter, with robust sales expected to commence in both Q4 and Q1 2025.
Adam Graziano, CEO of SIPP Industries, expressed his excitement about the Company's achievements: "This milestone marks a significant step forward for SIPP Industries and our partner, Calypso Pharmaceuticals. Our commitment to delivering high-quality cannabis-based products continues to drive our success in the market. We are thrilled to expand our offerings and reach more consumers, providing innovative solutions for health and wellness."
About SIPP Industries
SIPP Industries is a multifaceted corporation specializing in the manufacturing and distribution of commercial and consumer products within the cannabis industry.
Website: https://www.sippindustries.com
Facebook: https://www.facebook.com/SippIndustries
X: @SippIndustries
About Calypso Pharmaceuticals
Calypso Pharmaceuticals, based in Dallas, Texas, is on a mission to establish a leading global brand with the most comprehensive portfolio of innovative cannabis-based therapeutics.
The company is dedicated to creating products that ensure a healthy and comfortable life, formulating a wide range of medications for chronic conditions such as Alzheimer's, anxiety, chronic pain, depression, melanoma, obesity, and more. Calypso Pharmaceuticals aims to provide a calm and satisfactory experience in administering and utilizing cannabis-based medicine.
TEXASOIL
5 meses hace
NEWS OUT!
COSTA MESA, Calif., June 25, 2024 (GLOBE NEWSWIRE) -- SIPP Industries, Inc. (OTC: SIPC), a multifaceted corporation specializing in the manufacturing and distribution of commercial and consumer products in the cannabis industry, is pleased to announce the appointment of Adam Graziano as the new Chief Executive Officer, effective immediately.
Jakob Jorgensen, the former CEO of SIPP Industries, will remain a business consultant while also joining Calypso Pharmaceuticals as their new CEO. Mr. Jorgensen's new role will focus on advancing the recent research and development agreement between Calypso Pharmaceuticals and SIPP Industries. This collaboration aims to develop a groundbreaking topical treatment utilizing Peptide P16, designed to penetrate and destroy melanoma cells. Additionally, the partnership will explore the potential of other peptides in combating obesity, anxiety, Alzheimer’s disease, and various other conditions.
Adam Graziano brings a wealth of experience and leadership to SIPP Industries. With 20 years in various business leadership roles and over 33 years in the insurance sector, while currently managing a $500 million portfolio, Mr. Graziano has consistently demonstrated his ability to guide teams in achieving and surpassing growth and financial objectives. He holds a Bachelor of Arts in Political Science with a minor in Criminal Justice from St. Cloud State University.
"We are excited to welcome Adam Graziano to the SIPP Industries family," said Jakob Jorgensen. "His extensive experience and proven leadership will be invaluable as we continue to innovate and expand our footprint in the pharmaceutical sector."
Adam Graziano expressed his enthusiasm for joining the Company, stating, "I am honored to lead SIPP Industries into its next chapter. I look forward to working with the talented team here to drive growth and deliver exceptional products and services to our customers."
SIPP Industries remains committed to its mission of developing and distributing high-quality cannabis products while pursuing innovative research and development initiatives. The company is confident that, under Mr. Graziano's leadership, it will continue to achieve significant milestones and set new standards in the industry.
About Sipp Industries, Inc.
Sipp Industries is a multifaceted corporation specializing in manufacturing and distribution of commercial and consumer products within the cannabis industry.
Website: http://www.sippindustries.com
Facebook: https://www.facebook.com/SippIndustries
Twitter: @SippIndustries
About Calypso Pharmaceuticals
Calypso Pharmaceuticals is a Texas-based company known for its innovative products and proprietary technologies in the pharmaceutical, cannabis, and hemp sectors. The company is committed to advancing therapeutic solutions that improve patient outcomes and quality of life.
Website: https://calypsopharmaceuticals.com
Forward-Looking Statements:
This release contains forward-looking statements within the meaning of Section 27a of the Securities Act of 1933, as amended and section 21e of the Securities and Exchange Act of 1934, as amended. Those statements include the intent, belief or current expectations of the Company and its management team. Forward-looking statements are projections of events, revenues, income, future economics, research, development, reformulation, product performance or management’s plans and objectives for future operations. Some or all of the events or results anticipated by these forward-looking statements may not occur. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. Accomplishing the strategy described herein is significantly dependent upon numerous factors, many that are not in management’s control.
Contact:
Sipp Industries, Inc.
Investor Relations
ir@sippindustries.com
molee
6 meses hace
$SIPC > New sheriff in town >>> UP we go ...
SIPP Industries Appoints Adam Graziano as New CEO to Lead Next Chapter of Growth and Innovation
COSTA MESA, Calif., June 25, 2024 (GLOBE NEWSWIRE) -- SIPP Industries, Inc. (OTC: SIPC), a multifaceted corporation specializing in the manufacturing and distribution of commercial and consumer products in the cannabis industry, is pleased to announce the appointment of Adam Graziano as the new Chief Executive Officer, effective immediately.
Jakob Jorgensen, the former CEO of SIPP Industries, will remain a business consultant while also joining Calypso Pharmaceuticals as their new CEO. Mr. Jorgensen's new role will focus on advancing the recent research and development agreement between Calypso Pharmaceuticals and SIPP Industries. This collaboration aims to develop a groundbreaking topical treatment utilizing Peptide P16, designed to penetrate and destroy melanoma cells. Additionally, the partnership will explore the potential of other peptides in combating obesity, anxiety, Alzheimer’s disease, and various other conditions.
Adam Graziano brings a wealth of experience and leadership to SIPP Industries. With 20 years in various business leadership roles and over 33 years in the insurance sector, while currently managing a $500 million portfolio, Mr. Graziano has consistently demonstrated his ability to guide teams in achieving and surpassing growth and financial objectives. He holds a Bachelor of Arts in Political Science with a minor in Criminal Justice from St. Cloud State University.
"We are excited to welcome Adam Graziano to the SIPP Industries family," said Jakob Jorgensen. "His extensive experience and proven leadership will be invaluable as we continue to innovate and expand our footprint in the pharmaceutical sector."
Adam Graziano expressed his enthusiasm for joining the Company, stating, "I am honored to lead SIPP Industries into its next chapter. I look forward to working with the talented team here to drive growth and deliver exceptional products and services to our customers."
SIPP Industries remains committed to its mission of developing and distributing high-quality cannabis products while pursuing innovative research and development initiatives. The company is confident that, under Mr. Graziano's leadership, it will continue to achieve significant milestones and set new standards in the industry.
About Sipp Industries, Inc.
Sipp Industries is a multifaceted corporation specializing in manufacturing and distribution of commercial and consumer products within the cannabis industry.
Website: http://www.sippindustries.com
Facebook: https://www.facebook.com/SippIndustries
Twitter: @SippIndustries
About Calypso Pharmaceuticals
Calypso Pharmaceuticals is a Texas-based company known for its innovative products and proprietary technologies in the pharmaceutical, cannabis, and hemp sectors. The company is committed to advancing therapeutic solutions that improve patient outcomes and quality of life.
Website: https://calypsopharmaceuticals.com
Forward-Looking Statements:
This release contains forward-looking statements within the meaning of Section 27a of the Securities Act of 1933, as amended and section 21e of the Securities and Exchange Act of 1934, as amended. Those statements include the intent, belief or current expectations of the Company and its management team. Forward-looking statements are projections of events, revenues, income, future economics, research, development, reformulation, product performance or management’s plans and objectives for future operations. Some or all of the events or results anticipated by these forward-looking statements may not occur. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. Accomplishing the strategy described herein is significantly dependent upon numerous factors, many that are not in management’s control.
Contact:
Sipp Industries, Inc.
Investor Relations
ir@sippindustries.com